Caitong Securities(SH:601108) Xin Lang Cai Jing·2025-11-25 05:40Group 1 - The core viewpoint of the news is that Zhendong Pharmaceutical has seen a stock price increase of 5.31%, reaching 6.74 CNY per share, with a total market capitalization of 6.688 billion CNY as of the report date [1] - Zhendong Pharmaceutical, established on November 15, 1995, and listed on January 7, 2011, is located in Changzhi City, Shanxi Province. The company specializes in the research, production, and sales of generic and innovative drugs related to oncology, hair, digestion, urology, and cardiovascular diseases, as well as a full industry chain of traditional Chinese medicine [1] - The revenue composition of Zhendong Pharmaceutical includes 54.82% from traditional Chinese medicine, 43.10% from chemical drugs, 1.98% from other sources, and 0.10% from sales materials, with no revenue from research and development [1] Group 2 - From the perspective of fund holdings, Zhendong Pharmaceutical is a significant investment for the Caifeng Securities Asset Management's healthcare mixed fund A (018484), which held 800,000 shares, accounting for 6.04% of the fund's net value, ranking as the ninth largest holding [2] - The Caifeng Securities Asset Management healthcare mixed fund A (018484) was established on August 3, 2023, with a latest scale of 64.306 million CNY. The fund has achieved a year-to-date return of 20.51%, ranking 3452 out of 8136 in its category [2] - The fund manager of Caifeng Securities Asset Management healthcare mixed fund A is Wang Xinyuan, who has been in the position for 16 days, with the fund's total asset size at 359 million CNY [3]